Reed Shafer-Ray – USA

COVID-19 VXCO-100 vaccine Phase I study, 2023
"I chose to receive an experimental Covid vaccine that could one day make vaccines cheaper, more effective, and more widely accessible. The decision to participate was easy — I would take slight inconvenience for the opportunity to save just one life, much less millions."